SCHEMBL13625185

SCHEMBL13625185

CC(C)(C)Nc1ncc(N2CCN(C(=O)OC(C)(C)C)CC2)cc1-c1nc2ccccc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.43
CKS1B P61024 2/20 0.42
SKP1 P63208 2/20 0.42
SKP2 Q13309 2/20 0.42
GBA1 P04062 2/20 0.42
CCNK O75909 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCND3 P30281 1/20 0.41
CDK9 P50750 1/20 0.41
CDK6 Q00534 1/20 0.41
KIT P10721 1/20 0.41
PIK3CA P42336 2/20 0.41
SMARCA2 P51531 1/20 0.41
SMARCA4 P51532 1/20 0.41
PBRM1 Q86U86 1/20 0.41
PTPN11 Q06124 1/20 0.40
PDK2 Q15119 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13625189 0.83 MET (0.52) METPIK3CASMARCA2SMARCA4PBRM1
SCHEMBL13625278 0.78 ELANE (0.44) MEN1MAPTTSHRKMT2A
SCHEMBL13625277 0.76 NPSR1 (0.48) MEN1MAPTTSHRKMT2A
SCHEMBL4054998 0.75 AKR1C3 (0.61) METCKS1BSKP1SKP2GBA1
SCHEMBL31254486 0.75 AKR1C3 (0.61) METCKS1BSKP1SKP2GBA1
SCHEMBL4058660 0.74 GAA (0.64) CKS1BSKP1SKP2GBA1PIK3CA
SCHEMBL13625130 0.72 KDM4E (0.44) METMEN1MAPTTSHRKMT2A
SCHEMBL6352963 0.72 CKS1B (0.58) METCKS1BSKP1SKP2GBA1
SCHEMBL31254494 0.72 CKS1B (0.58) METCKS1BSKP1SKP2GBA1
SCHEMBL13625191 0.71 MET (0.50) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009139576-A2 PYRIDINE DERIVATIVES SUBSTITUTED WITH NOVEL BENZOXAZOLES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS ACTIVE INGREDIENTS FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH DISEASE 한국화학연구원 (KR) 2009-11-19 WO disclosed